EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The m7G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling

Jiancong Xie, Taiwei Mo iD, Ruibing Li, Hao Zhang, Guanzhan Liang, Tao Ma, Jing Chen, Hanlin Xie, Xiaofeng Wen, Tuo Hu iD, Zhenyu Xian iD, Weidong Pan iD

Cancers · 17.11.2023 · 15 (22) · 5454

DOI: 10.3390/cancers15225454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 17.11.2023. Verfasst von Jiancong Xie und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery (Pancreatic Hepatobiliary Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regional Joint Project for Guangdong Basic and Applied Basic Research Foundation, Starting Funding of Faculty from Sun Yat-sen University, Guangzhou Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PDAC is one of the most common malignant tumors worldwide. The difficulty of early diagnosis and lack of effective treatment are the main reasons for its poor prognosis. Therefore, it is urgent to identify novel diagnostic and therapeutic targets for PDAC patients. The m7G methylation is a common type of RNA modification that plays a pivotal role in regulating tumor development. However, the correlation between m7G regulatory genes and PDAC progression remains unclear. By integrating gene expression and related clinical information of PDAC patients from TCGA and GEO cohorts, m7G binding protein NCBP2 was found to be highly expressed in PDAC patients. More importantly, PDAC patients with high NCBP2 expression had a worse prognosis. Stable NCBP2-knockdown and overexpression PDAC cell lines were constructed to further perform in-vitro and in-vivo experiments. NCBP2-knockdown significantly inhibited PDAC cell proliferation, while overexpression of NCBP2 dramatically promoted PDAC cell growth. Mechanistically, NCBP2 enhanced the translation of c-JUN, which in turn activated MEK/ERK signaling to promote PDAC progression. In conclusion, our study reveals that m7G reader NCBP2 promotes PDAC progression by activating MEK/ERK pathway, which could serve as a novel therapeutic target for PDAC patients.

Schlagwörter

Stichwörter der Autor:innen

MEK/ERKNCBP2c-JUNm7G methylationpancreatic adenocarcinoma

Autor:innen und Institutionen

  • Department of General Surgery (Pancreatic Hepatobiliary Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.
  • Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
  • Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.
  • Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.
  • Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.

ORCID-Profile: Taiwei Mo, Tuo Hu, Zhenyu Xian, Weidong Pan

Förderung

  • Regional Joint Project for Guangdong Basic and Applied Basic Research Foundation
  • Starting Funding of Faculty from Sun Yat-sen University
  • Guangzhou Basic and Applied Basic Research Foundation
  • Fundamental Research Funds for the Central Universities, Sun Yat-sen University
  • National Key Clinical Discipline and the Discipline Construction Funding for Pancreatic and Hepatobiliary Surgery Department of the Sixth Affiliated Hospital o…
  • "1010" clinical research program from the Sixth Affiliated Hospital of Sun Yat-sen University
  • Wu Jieping Medical Foundation Project
  • National Natural Science Foundation of China

Zitieren

APA

Xie, J., Mo, T., Li, R., Zhang, H., Liang, G., Ma, T., Chen, J., Xie, H., Wen, X., Hu, T., Xian, Z., & Pan, W. (2023). The m7G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling. Cancers, 15(22), 5454. https://doi.org/10.3390/cancers15225454

Vancouver

Xie J, Mo T, Li R, Zhang H, Liang G, Ma T, et al. The m7G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling. Cancers. 2023;15(22):5454. doi:10.3390/cancers15225454

BibTeX
@article{Xie2023,
  author = {Xie, Jiancong and Mo, Taiwei and Li, Ruibing and Zhang, Hao and Liang, Guanzhan and Ma, Tao and Chen, Jing and Xie, Hanlin and Wen, Xiaofeng and Hu, Tuo and Xian, Zhenyu and Pan, Weidong},
  title = {The m7G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {22},
  pages = {5454},
  doi = {10.3390/cancers15225454}
}
Kostenlos starten →